We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Moser, H. W. (1993) Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope. Annals of Neurology, 34, 121–122.Google ScholarPubMed
Moser, H. W., Moser, A. B., Smith, K. D., et al (1992) Adrenoleukodystrophy: phenotypic variability and implications for therapy. Journal of Inherited Metabolic Disorders, 15, 645–664.CrossRefGoogle ScholarPubMed
Poulos, A., Gibson, R., Sharp, P., et al (1994) Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Annals of Neurology, 36, 741–746.CrossRefGoogle ScholarPubMed
Walker, N. P., Fox, H. C. & Whalley, L. J. (1999) Lipids and schizophrenia. British Journal of Psychiatry174, 101–104.Google ScholarPubMed
Zinkham, W. H., Kidder, T., Borel, M. S., et al (1993) Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy. New England Journal of Medicine, 328, 1126–1127.CrossRefGoogle ScholarPubMed
eLetters
No eLetters have been published for this article.